Health Claim: Plant Stanol Esters and Heart Disease | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2000-P-0133

Health Claim: Plant Stanol Esters and Heart Disease

Documents

Comments

Description

Docket Status: CLOSED

Comment Period OpensSep 14, 2000

Comment Period ClosesApr 24, 2012

Type	Title	Posted	Comments	Status
Other	Petition Response Letter from FDA CDER to Mr Raubicheck on behalf of Pharmachem Laboratories Inc.	May 26, 2020	--

Total Comments

CHOLESTEROL-LOWERING

NUTRIOUS VALUE

REDUCING RISK OF CHD

DIETARY CHANGE BY CLAIM

ADVERSE REACTION

PLANT STANOL ESTERS

FOOD SUBSTANCE

CFSAN

CLOSED